Related Experiment Video
Updated: May 13, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
[Hemolytic uremic syndrome caused by Shiga-toxin-producing Escherichia coli]
1Service de néphrologie, AP-HP, hôpital Robert-Debré, 75019 Paris, France. chantal.loirat@rdb.aphp.fr
Insights
Shiga toxin-producing E. coli (STEC) causes hemolytic uremic syndrome (HUS) in about 100 French children annually. Prevention through simple hygiene methods and public awareness is crucial, as treatments remain largely supportive.
Area of Science:
- Infectious Diseases
- Pediatrics
- Nephrology
Context:
- Shiga toxin-producing Escherichia coli (STEC) infections frequently cause hemolytic uremic syndrome (HUS) in young children in France.
- STEC-HUS affects approximately 100 children aged 6 months to 3 years annually, with transmission via contaminated food or household contact.
- Adults are less commonly affected, except during specific outbreaks.
Purpose:
- To summarize the epidemiology, clinical features, treatment, and prevention of STEC-HUS in France.
- To highlight the importance of public awareness and surveillance in managing STEC-HUS.
Summary:
- STEC-HUS has a 1-2% mortality rate, with 50% of patients requiring acute dialysis.
- While most children recover renal function, 30% experience long-term sequelae, particularly if anuria exceeds 5 days.
- Current treatments are primarily supportive, with uncertain efficacy for plasma exchange and eculizumab.
Impact:
- Emphasizes the need for improved public education on simple prevention methods for STEC-HUS.
- Highlights the role of surveillance systems like those from Institut de veille sanitaire in early outbreak detection and control.
- Underscores the potential for preventing new cases through market withdrawal of contaminated food and public information dissemination.
Abstract:
Every year in France, approximately one hundred children, aged from 6 months to 3 years, develop hemolytic uremic syndrome (HUS) secondary to Shiga toxin-producing Escherichia coli (STEC) infection, mostly the O157:H7 serotype. Except during outbreaks, STEC-HUS is less frequent in adults. The main route of transmission is the consumption of undercooked ground beef or unpasteurized dairy products, or household contacts with STEC diarrhea. Mortality is 1 to 2%. Half of patients require dialysis at the acute phase, the majority will recover normal renal function but approximately 30% will suffer renal sequelae. The risk of sequelae is important if the duration of anuria has been more than 5 days. Treatment of STEC-HUS is mostly supportive. The efficacy of plasma exchanges is not demonstrated and that of eculizumab, a complement blocker, especially in case of central nervous system or cardiac involvement, uncertain. Prevention of STEC-HUS relies on simple methods, often unknown of parents of young children, with the French general population being scarcely informed. However, the surveillance of STEC-infections/HUS by the Institut de veille sanitaire and the Reference Center for E. coli infections allows the early detection of outbreaks and their source of contamination. This prevents the emergence of new cases by withdrawing the suspected food from the market and diffusing the information to the population (return of suspected food).
Related Concept Videos
Bacterial Gastroenteritis
Cholera
Stringent Response in E. coli
Hepatic Encephalopathy
Bacterial Toxins
Reservoir of Infection

